References
- FreemanRBaronRBouhassiaraDCabreraJEmirBSensory profiles of patients with neuropathic pain based on neuropathic pain symptoms and signsPain201415536737624472518
- PhillipsTJCCherryCLCoxSMarshallSJRiceASCPharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trialsPLoS ONE20105e1443321203440
- Robinson-PappJMorgelloSVaidaFAssociation of self-reported painful symptoms with clinical and neurophysiological signs in HIV-associated sensory neuropathyPain201015173273620851521
- RobertsonKKumwendaJSupparatpinyoKA multinational study of neurological performance in antiretroviral therapy-naive HIV-1-infected persons in diverse resource-constrained settingsJ Neurovirol20111743844721786076
- SchützSGRobinson-PappJHIV-related neuropathy: current perspectivesHIV/AIDS (Auckl)20135243251
- VermaSEstanislaoLSimpsonDHIV-associated neuropathic pain: epidemiology, pathophysiology and managementCNS Drugs20051932533415813646
- KemperCAKentGBurtonSDeresinskiSCMexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trialJ Acquir Immune Defic Syndr Hum Retrovirol1998193673729833745
- KieburtzKSimpsonDYiannoutsosCA randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol TeamNeurology199851168216889855523
- ShlayJCChalonerKMaxMBAcupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized control trialJAMA1998280159015959820261
- SimpsonDMDorfmanDOlneyRKPeptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trialNeurology199647125412598909439
- AttalNCruccuGBaronREuropean Federation of Neurological SocietiesEFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEur J Neurol2010171113e8820402746
- DworkinRHO’ConnorABBackonjaMPharmacologic management of neuropathic pain: evidence-based recommendationsPain200713223725117920770
- EstanislaoLCarterKMcArthurJOlneyRSimpson D; GroupL-HNA randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathyJ Acquir Immune Defic Syndr2004371584158615577414
- BrockmannWGMepivacaine: a closer look at its properties and current utilityGen Dent201462707525369391
- RadwanIASaitoSGotoFThe neurotoxicity of local anesthetics on growing neurons: a comparative study of lidocaine, bupivacaine, mepivacaine, and ropivacaineAnesth Analg20029431932411812691
- LeeHIParkYSChoTGParkSWKwonJTKimYBTransient adverse neurologic effects of spinal pain blocksJ Korean Neurosurg Soc20125222823323115666
- HerzbergUSagenJPeripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosisJ Neuroimmunol2001116293911311327
- WallaceVCBlackbeardJPhebyTPharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathyPain2007133476317433546
- ApostolskiSMcAlarneyTHaysAPLatovNComplement dependent cytotoxicity of sensory ganglion neurons mediated by the gp120 glycoprotein of HIV-1Immunol Invest19942347528144198
- MilliganEDMehmertKKHindeJLThermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120Brain Res200086110511610751570
- OhSBTranPBGillardSEHurleyRWHammondDLMillerRJChemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neuronsJ Neurosci2001215027503511438578
- KeswaniSCPolleyMPardoCAGriffinJWMcArthurJCHokeASchwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neuronsAnn Neurol20035428729612953261
- JonesGZhuYSilvaCPeripheral nerve-derived HIV-1 is predominately CCR5-dependent and causes neuronal degeneration and neuroinflammationVirology200533417819315780868
- MelliGKeswaniSCFischerAChenWHokeASpatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathyBrain20061291330133816537566
- BabulNHamaABaslerABaumJSagenJResponse to the local anesthetic TQ-1019 in the GP120 model of painful HIV neuropathy12th World Congress on PainAug, 17–24, 2012Glasgow, Scotland Abstract PW350
- RusakovaLBabulNCastellanosDWeinrichJBaumDSagenJAntinociceptive response of the local anesthetic TQ-1019 in the radiant heat tail flick assay12th World Congress on PainAug, 17–24, 2012Glasgow, Scotland Abstract PW353
- HargreavesKDubnerRBrownFFloresCJorisJA new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPain19883277883340425
- AnitescuMBenzonHTArgoffCEAdvances in topical analgesicsCurr Opin Anesthesiol201326555561
- WiffenDSMooreRAQuinlanJTopical lidocaine for neuropathic pain in adultsCochrane Database Syst Rev20147CD01095825058164
- KolesnikovYAChereshnevIPasternakGWAnalgesic synergy between topical lidocaine and topical opioidsJ Pharmacol Exp Ther200029554655111046087
- GhoshRKGhoshSMChawlaSRecent advances in antiretroviral drugsExpert Opin Pharmacother201112314620698725
- EllisRJToperoffWVaidaFSmoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trialNeuropsychopharmacology20093467268018688212
- AbramsDIJayCAShadeSBCannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trialNeurology20076851552117296917
- PaiceJAFerransCELashleyFRVizgirdaVPitrakDTopical capsaicin in the management of HIV-associated peripheral neuropathyJ Pain Symptom Manage200019455210687326
- SimpsonDMBrownSTobiasJNGX-4010 C107 Study GroupControlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathyNeurology2008702305231318541884
- SimpsonDMEstanislaoLBrownSHSampsonJAn open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathyJ Pain Symptom Manage20083529930617959343
- SimpsonDMBrownSTobiasJKVanhoveGFNGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathyClin J Pain20143013414223446088
- SimpsonDMMcArthurJCOlneyRLamotrigine HIV Neuropathy Study TeamLamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trialNeurology2003601508151412743240
- SimpsonDMOlneyRMcArthurJCKhanAGodboldJEbel-FrommerKA placebo-controlled trial of lamotrigine for painful HIV-associated neuropathyNeurology2000542115211910851374
- BaronRPeripheral neuropathic pain: from mechanisms to symptomsClin J Pain200016S12S2010870735
- NasirinezhadFJergovaSPearsonJPSagenJAttenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat mode of HIV sensory neuropathyNeuropharmacology20159510010925486617
- SorkinLSXiaoWHWagnerRMyersRRTumour necrosis factor-alpha indices ectopic activity in nociceptive primary afferent fibersNeuroscience1997812552629300418
- FloresMPCastroAPNascimentoJSTopical analgesicsRev Bras Anestesiol20126224425422440379
- KirillovaITeilbanAGorodetskayaNEffect of local and intravenous lidocaine on ongoing activity in injured afferent nerve fibersPain20111521562157121474243
- DeversAGalerBSTopical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label studyClin J Pain20001620520811014393
- MeierTWasnerGFaustMEfficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled studyPain20031615115814581122
- MadsenCSJohnsenBJFulglsang-FrederiksenAJensenTSFinnerupNBDifferential effects of a 5% lidocaine medicated patch in peripheral nerve injuryMuscle Nerve20134826527123653369
- PeppinJFAlbrechtPJArgoffCSkin matters: a review of topical treatments for chronic pain. Part two: treatments and applicationsPain Ther20154335025630651
- ChoCWChoiJSShinSCEnhanced local anesthetic action of mepivacaine from the bioadhesive gelsPak J Pharm Sci201124879321190925
- KangCShinSCDevelopment of prilocaine gels for enhanced local anesthetic actionArch Pharm Res2012351197120422864742